BioPharma Drug Discovery
Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Japanese government will purch...
November 11, 2021 | News
Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
Oncodesign (ALONC – FR0011766229), a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio (K...
October 22, 2021 | News
Phillips-Medisize Increases Global Manufacturing Capacity
Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers in Poland,&n...
October 20, 2021 | News
MSN Labs Launches Empagliflozin tablets at an affordable price for Diabetes Management in India
‘EMPAONE’ is intended to provide diabetes patients in need across India with an affordable and accessible therapeutic option. India being the d...
October 19, 2021 | News
Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection
The BiCNU® brand and generic market had U.S. sales of approximately $19.4 million MAT for the most recent twelve months ending in August 2021 a...
October 18, 2021 | News
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment pro...
October 14, 2021 | News
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat&re...
October 13, 2021 | News
Luciole ,Cyclica to Accelerate Discovery of Novel Medicine
"Luciole aims to be the premier mitochondrial repair company by applying state-of-theart technology and an efficient, virtual company approach to developin...
October 07, 2021 | News
South Korea Advances Treatment of Polymyositis
Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...
September 28, 2021 | News
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002
Currently there are over 100 million of people with various degree of osteoporosis and 4 million people in China with severe osteoporos...
September 27, 2021 | News
Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan
Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market Mirum P...
September 23, 2021 | News
Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer
ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...
September 23, 2021 | News
Happiness Biotech Announced The Launch of Its Lucidum Tablets
"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...
September 13, 2021 | News
Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech
Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharm...
September 09, 2021 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
